title: Asymptomatic anti-HCV seropositive subjects include patients with chronic active hepatitis and individuals with normal liver: can we distinguish them?
authors.forename: P
authors.initials: P
authors.lastname: Manzini
authors.forename: P L
authors.initials: PL
authors.lastname: Calvo
authors.forename: M L
authors.initials: ML
authors.lastname: Abate
authors.forename: A
authors.initials: A
authors.lastname: Cerchier
authors.forename: P
authors.initials: P
authors.lastname: Piantino
authors.forename: P
authors.initials: P
authors.lastname: Vallauri
authors.forename: S
authors.initials: S
authors.lastname: D'Antico
authors.forename: B
authors.initials: B
authors.lastname: Sympson
authors.forename: R
authors.initials: R
authors.lastname: Klarmann
authors.forename: M
authors.initials: M
authors.lastname: Schiffer
mesh_terms: D001706:Biopsy; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005500:Follow-Up Studies; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology; D018937:Hepatitis C Antibodies; D006801:Humans; D015151:Immunoblotting / Q000379:methods; D008099:Liver / Q000473:pathology; D008111:Liver Function Tests; D016133:Polymerase Chain Reaction / Q000379:methods; D012016:Reference Values
chemical_list: D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies